Search results for: Innovation Policy Prize

Carer quality of life in HTA: from measurement to economic models

17 September 2026, 1:00pm

…Senior Economist Cancellation & Refund Policy Participants may cancel their registration and receive a full refund up to 48 hours before the start of the masterclass. For cancellations made less…

OHE Annual Lecture 2022 | Universal Health Coverage: More Than Just Old Wine in a New Bottle?

6 October 2022, 6:00pm

…Erasmus School of Health Policy and Management, both at Erasmus University Rotterdam. He studied econometrics in Antwerp (B), and health economics in York (UK), and obtained his PhD at Maastricht…

OHE Academy

…whom? At what cost?  Discover more about Health Economics here  Why does OHE prioritise advancing health economics education?  We believe that better health policy starts with better understanding. Health Economics…

Assessing Value, Budget Impact and Affordability to Inform Discussions on Access and Reimbursement: Principles and Practice, with Special Reference to High Cost Technologies

1 April 2017

The 2016 meeting of the HTAi Asia Policy Forum meeting was held in Kuala Lumpur, 17th -18th November 2016. The topic of the meeting was: Assessing Value, Budget Impact and…

Achieving Accelerated Patient Access to Cancer Care in Europe 

3 November 2025

…Additional policy dialogue is required to address outstanding challenges. OHE developed a set of recommendations to progress the implementation of APACE including developing consistent methods for assessing uncertainty, defining relevant…

Bridging the Gap: Pathways for Regulatory and Health Technology Assessment of Histology Independent Therapies

8 January 2020

…policy hurdles related to evidence development and acceptance, value assessment and reimbursement pathways,… Histology independent therapies, a new class of medicines that target cancer based on specific genomic or molecular…

Victoria Jordan

21 January 2026

…At the ABPI, Vic leads on access related policy strategy and the delivery of a work programme that seeks to ensure new medicines are made available to NHS patients with…

Understanding the preferences of people with acute leukemia for different health outcomes

25 September 2025

…also be important in some disease contexts.  Patient voice should guide care and policy.  Differences between patient and public priorities highlight the importance of incorporating patient-reported outcomes into both clinical…

NICE at 25: Technology Appraisals – Faster Access to Modern Treatment?

1 May 2024

…an “end-of-life” policy. This effectively increased the threshold for medicines that met specific criteria, including extending life expectancy for patients by at least three months. In recognition of innovations in…